Sanctuary Advisors LLC Lowers Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Sanctuary Advisors LLC reduced its position in Doximity, Inc. (NASDAQ:DOCS) by 31.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,579 shares of the company’s stock after selling 3,080 shares during the quarter. Sanctuary Advisors LLC’s holdings in Doximity were worth $317,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. MetLife Investment Management LLC grew its holdings in shares of Doximity by 0.6% in the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock valued at $2,835,000 after purchasing an additional 363 shares in the last quarter. First Horizon Advisors Inc. grew its stake in shares of Doximity by 22.5% in the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock worth $91,000 after acquiring an additional 384 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after acquiring an additional 412 shares in the last quarter. Van ECK Associates Corp increased its position in shares of Doximity by 19.7% during the second quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock worth $72,000 after acquiring an additional 427 shares during the period. Finally, Cornercap Investment Counsel Inc. raised its stake in shares of Doximity by 3.2% in the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock valued at $479,000 after acquiring an additional 537 shares in the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

DOCS has been the subject of several analyst reports. Morgan Stanley raised Doximity from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $33.00 to $53.00 in a research note on Thursday, November 14th. JPMorgan Chase & Co. upped their target price on shares of Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a research note on Thursday, November 21st. Robert W. Baird raised their target price on shares of Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a report on Tuesday, September 17th. Mizuho assumed coverage on shares of Doximity in a report on Wednesday, December 4th. They set a “neutral” rating and a $55.00 price target for the company. Finally, Raymond James restated an “outperform” rating and issued a $65.00 price objective (up from $37.00) on shares of Doximity in a report on Friday, November 8th. Thirteen investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $52.59.

Doximity Stock Performance

Shares of DOCS opened at $57.78 on Friday. The company’s 50 day simple moving average is $50.59 and its 200 day simple moving average is $39.80. The company has a market capitalization of $10.79 billion, a price-to-earnings ratio of 66.41, a PEG ratio of 4.16 and a beta of 1.40. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $61.75.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.